Valuation: Giant Biogene Holding Co., Ltd.

Capitalization 3.38TCr 3.77TCr 484.07Cr 414.51Cr 385.48Cr 359.38Cr 671.51Cr 44TCr 720.24Cr 4.44TCr 1.75TCr 21TCr 1.82TCr 1.78TCr 77TCr P/E ratio 2025 *
15.7x
P/E ratio 2026 * 13x
Enterprise value 2.78TCr 3.11TCr 398.29Cr 341.06Cr 317.17Cr 295.7Cr 552.52Cr 36TCr 592.62Cr 3.65TCr 1.44TCr 17TCr 1.49TCr 1.46TCr 63TCr EV / Sales 2025 *
4.62x
EV / Sales 2026 * 3.66x
Free-Float
42.68%
Yield 2025 *
3.47%
Yield 2026 * 3.9%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.35%
1 week+6.33%
Current month+8.05%
1 month+2.45%
3 months-29.42%
6 months-36.63%
Current year+8.05%
More quotes
1 week 33.84
Extreme 33.84
36.48
1 month 32.88
Extreme 32.88
36.58
Current year 32.88
Extreme 32.88
36.48
1 year 32.88
Extreme 32.88
87.1
3 years 28.4
Extreme 28.4
87.1
5 years 24.3
Extreme 24.3
87.1
10 years 24.3
Extreme 24.3
87.1
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 21/04/2022
Director of Finance/CFO 39 21/04/2022
Corporate Secretary 30 01/10/2018
Director TitleAgeSince
Chairman 59 21/04/2022
Director/Board Member 55 30/11/2021
Director/Board Member 67 06/10/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.35%+6.33%-26.24%+1.44% 469.68Cr
+1.12%+2.20%-9.52%-4.24% 33TCr
+0.56%+1.52%-6.41%+1.32% 14TCr
+1.42%+0.93%-1.83%-7.10% 6.8TCr
+0.55%+6.50%-5.13%+6.62% 6.57TCr
-0.62%+4.49%+53.87%-56.90% 4.1TCr
+1.01%+1.07%-18.47% - 3.22TCr
+3.12%+4.39%-22.32%-9.42% 2.42TCr
0.00%+0.96%-9.40%-9.28% 1.95TCr
+0.54%-0.65%+6.66%+35.08% 1.39TCr
Average +0.95%+2.18%-3.88%-4.72% 7.39TCr
Weighted average by Cap. +0.94%+2.39%-4.93%-4.97%
See all sector performances

Financials

2025 *2026 *
Net sales 601.07Cr 672.05Cr 86Cr 74Cr 69Cr 64Cr 119.58Cr 7.77TCr 128.25Cr 790.74Cr 310.82Cr 3.72TCr 323.26Cr 316.63Cr 14TCr 733.87Cr 820.53Cr 105.24Cr 90Cr 84Cr 78Cr 146Cr 9.49TCr 156.59Cr 965.44Cr 379.5Cr 4.54TCr 394.68Cr 386.59Cr 17TCr
Net income 215.55Cr 241Cr 31Cr 26Cr 25Cr 23Cr 43Cr 2.79TCr 46Cr 283.56Cr 111.46Cr 1.33TCr 115.92Cr 113.55Cr 4.89TCr 259.13Cr 289.73Cr 37Cr 32Cr 30Cr 28Cr 52Cr 3.35TCr 55Cr 340.89Cr 134Cr 1.6TCr 139.36Cr 136.5Cr 5.87TCr
Net Debt -598.12Cr -668.74Cr -86Cr -73Cr -68Cr -64Cr -118.99Cr -7.73TCr -127.62Cr -786.85Cr -309.29Cr -3.7TCr -321.67Cr -315.08Cr -14TCr -690.8Cr -772.37Cr -99Cr -85Cr -79Cr -74Cr -137.43Cr -8.93TCr -147.4Cr -908.78Cr -357.22Cr -4.27TCr -371.52Cr -363.9Cr -16TCr
More financial data * Estimated data
Logo Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co Ltd is a China-based investment holding company. The Company is principally engaged the research, development, manufacture and sale of bioactive material-based beauty and health products through its subsidiaries. The Company's main products include functional skincare products and medical dressings, and they are produced with recombinant collagen as the key bioactive ingredient. The Company also develops and manufactures rare ginsenosides technology-based functional foods. The Company mainly conducts its businesses within the domestic market.
Employees
2,162
More about the company
Date Price Change Volume
13/26/13 35.96 $ +1.35% 44,01,200
12/26/12 35.48 $ +3.08% 98,41,390
09/26/09 34.42 $ +0.06% 31,72,480
08/26/08 34.40 $ -0.81% 40,83,122
07/26/07 34.68 $ +1.17% 45,30,156

Delayed Quote Hong Kong S.E., January 13, 2026 at 08:50 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
35.48HKD
Average target price
54.09HKD
Spread / Average Target
+52.44%
Consensus

Quarterly revenue - Rate of surprise